Increased disparities associated with black women and abnormal cervical cancer screening follow-up.
Abnormal screening follow-up
Cervical cancer screening
HPV testing, lost to follow-up
Racial disparities
Journal
Gynecologic oncology reports
ISSN: 2352-5789
Titre abrégé: Gynecol Oncol Rep
Pays: Netherlands
ID NLM: 101652231
Informations de publication
Date de publication:
Aug 2022
Aug 2022
Historique:
received:
02
05
2022
revised:
26
06
2022
accepted:
02
07
2022
entrez:
28
7
2022
pubmed:
29
7
2022
medline:
29
7
2022
Statut:
epublish
Résumé
To determine whether race and ethnicity impacts patient adherence to follow-up for colposcopy after abnormal cervical cancer screening. This retrospective chart review included women that were randomly selected from patients presenting to our colposcopy clinic from 1/2019 to 12/2019. Inclusion criteria were females age ≥21 years-old and appropriate referral for colposcopy. Patients were grouped into three categories: (1) ADHERENT to follow-up if they came to their first scheduled appointment; (2) DELAYED if they presented more than three months from their original referral (usually missing 1-3 appointments); and (3) NOT ADHERENT if they did not show for their appointment after referral. Analysis was performed using SPSS v.26. 284 women met inclusion criteria for the study. The majority of women were Black (65.2 %) followed by non-Hispanic Whites (20.0 %) and Latinx (14.8 %). Overall, 39.1 % were ADHERENT, 18.6 % were DELAYED, and 42.3 % were NOT ADHERENT. When compared with non-Hispanic White women, there was a significant difference between race/ethnicity and timing of follow-up (p = 0.03). Blacks were more likely to be NOT ADHERENT (45.9 %; p = 0.03), and Latinx and Blacks were the most likely to be DELAYED (35.7 % and 21.1 %; p = 0.03). Private insurance patients were more likely to be ADHERENT for care compared with un-/underinsured patients (78.9 vs 27.8 %, p = 0.0001). There is inadequate follow-up after abnormal cervical cancer screening across all races/ethnicities; however, lack of adherence is higher in Black patients. Moreover, 25% of Hispanic and Black women present in a delayed fashion. Culturally relevant assessments and interventions are needed to understand and address these gaps.
Sections du résumé
Background
UNASSIGNED
To determine whether race and ethnicity impacts patient adherence to follow-up for colposcopy after abnormal cervical cancer screening.
Methods
UNASSIGNED
This retrospective chart review included women that were randomly selected from patients presenting to our colposcopy clinic from 1/2019 to 12/2019. Inclusion criteria were females age ≥21 years-old and appropriate referral for colposcopy. Patients were grouped into three categories: (1) ADHERENT to follow-up if they came to their first scheduled appointment; (2) DELAYED if they presented more than three months from their original referral (usually missing 1-3 appointments); and (3) NOT ADHERENT if they did not show for their appointment after referral. Analysis was performed using SPSS v.26.
Results
UNASSIGNED
284 women met inclusion criteria for the study. The majority of women were Black (65.2 %) followed by non-Hispanic Whites (20.0 %) and Latinx (14.8 %). Overall, 39.1 % were ADHERENT, 18.6 % were DELAYED, and 42.3 % were NOT ADHERENT. When compared with non-Hispanic White women, there was a significant difference between race/ethnicity and timing of follow-up (p = 0.03). Blacks were more likely to be NOT ADHERENT (45.9 %; p = 0.03), and Latinx and Blacks were the most likely to be DELAYED (35.7 % and 21.1 %; p = 0.03). Private insurance patients were more likely to be ADHERENT for care compared with un-/underinsured patients (78.9 vs 27.8 %, p = 0.0001).
Conclusion
UNASSIGNED
There is inadequate follow-up after abnormal cervical cancer screening across all races/ethnicities; however, lack of adherence is higher in Black patients. Moreover, 25% of Hispanic and Black women present in a delayed fashion. Culturally relevant assessments and interventions are needed to understand and address these gaps.
Identifiants
pubmed: 35898199
doi: 10.1016/j.gore.2022.101041
pii: S2352-5789(22)00121-7
pmc: PMC9309676
doi:
Types de publication
Journal Article
Langues
eng
Pagination
101041Subventions
Organisme : NCI NIH HHS
ID : P50 CA098252
Pays : United States
Informations de copyright
© 2022 Published by Elsevier Inc.
Déclaration de conflit d'intérêts
The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Teresa K. L. Boitano, Peter Ketch, Julia G. Maier, Christine T. Nguyen, J. Michael Straughn, Jr., and Isabel C. Scarinci declare no potential conflicts of interest. Warner K. Huh, declares NIH – P50 CA098252.
Références
Am J Public Health. 2011 Jul;101(7):1297-305
pubmed: 21566035
Cancer Epidemiol Biomarkers Prev. 2004 May;13(5):723-32
pubmed: 15159302
Prev Chronic Dis. 2019 Jun 06;16:E70
pubmed: 31172917
Patient Educ Couns. 2017 Jul;100(7):1353-1359
pubmed: 28190541
J Womens Health (Larchmt). 2014 Jan;23(1):57-64
pubmed: 24283674
J Womens Health (Larchmt). 2007 Apr;16(3):311-30
pubmed: 17439377
Cancer. 2009 Dec 15;115(24):5788-97
pubmed: 19859902
Cancer Epidemiol Biomarkers Prev. 2001 Oct;10(10):1015-20
pubmed: 11588126
Cancer. 2008 Nov 15;113(10 Suppl):2910-8
pubmed: 18980274
Am J Health Educ. 2013;44(6):293-298
pubmed: 24991653
Gynecol Oncol. 2021 Feb;160(2):369-374
pubmed: 33323276
Prev Med. 2000 Oct;31(4):429-39
pubmed: 11006069
Cancer. 2010 Jul 1;116(13):3195-204
pubmed: 20564623
J Gen Intern Med. 2010 Nov;25(11):1198-204
pubmed: 20652647
Cancer Causes Control. 2005 Sep;16(7):809-21
pubmed: 16132791
J Gen Intern Med. 2006 Aug;21(8):829-34
pubmed: 16881942
Psychooncology. 2004 Jun;13(6):408-28
pubmed: 15188447
Int J Cancer. 2019 Feb 15;144(4):687-696
pubmed: 30132850
J Health Care Poor Underserved. 2019;30(2):680-701
pubmed: 31130545
Health Serv Res. 2018 Aug;53 Suppl 1:2870-2891
pubmed: 28664993
Womens Health Issues. 2014 Jan-Feb;24(1):e155-62
pubmed: 24439942
Medicine (Baltimore). 2016 Aug;95(33):e4568
pubmed: 27537583
Cancer Causes Control. 2010 Jul;21(7):1081-90
pubmed: 20361353